Vectors and host cells comprising a modified sv40 promoter for protein expression
US-2016265018-A1 · Sep 15, 2016 · US
This page is not indexed by search engines while we improve data quality.
Abbvie Biotherapeutics Inc patents in 2016
Abbvie Biotherapeutics Inc was listed as an assignee on 10 patent publications in 2016.
| Metric | Value |
|---|---|
| Company | Abbvie Biotherapeutics Inc |
| Year | 2016 |
| Patents | 10 |
Patents
Representative publications for Abbvie Biotherapeutics Inc in 2016.
Compositions and methods using anti-cs1 antibodies to treat multiple myeloma
US-2016206734-A1 · Jul 21, 2016 · US
Fc variants with improved complement activation
US-2016137732-A1 · May 19, 2016 · US
Method of treating multiple myeloma using combination therapies based on anti-cs1 antibodies
US-2016137735-A1 · May 19, 2016 · US
DAC HYP compositions and methods
US-9340619-B2 · May 17, 2016 · US
Top CPC classifications
Most common classification codes for Abbvie Biotherapeutics Inc in 2016.
| CPC | Patents |
|---|---|
| A61K2039/505 | 7 |
| C07K2317/24 | 6 |
| A61P43/00 | 5 |
| C07K2317/56 | 5 |
| C07K2317/732 | 5 |
Related pages
Navigate to parent entity pages.